Soligenix
SNGX
#10820
Rank
NZ$9.24 M
Marketcap
NZ$0.62
Share price
-0.44%
Change (1 day)
-73.26%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2026 (TTM): -NZ$20.01 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$20.38 Million a decrease over its 2024 earnings that were of -NZ$16.08 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$20.01 Million-1.83%
2025 -NZ$20.38 Million26.72%
2024 -NZ$16.08 Million22.96%
2023 -NZ$13.08 Million-45.74%
2022 -NZ$24.1 Million11.88%
2021 -NZ$21.54 Million-32.37%
2020 -NZ$31.85 Million83.18%
2019 -NZ$17.39 Million11.57%
2018 -NZ$15.59 Million19.29%
2017 -NZ$13.07 Million33%
2016 -NZ$9.82 Million-19.7%
2015 -NZ$12.23 Million5.16%
2014 -NZ$11.63 Million
2010 -NZ$13.13 Million26.12%
2009 -NZ$10.41 Million75.1%
2008 -NZ$5.95 Million-45.38%
2007 -NZ$10.89 Million-22.84%
2006 -NZ$14.11 Million66.15%
2005 -NZ$8.49 Million-16.65%
2004 -NZ$10.19 Million13.28%
2003 -NZ$8.99 Million-11.88%
2002 -NZ$10.21 Million-59.44%
2001 -NZ$25.16 Million378.18%
2000 -NZ$5.27 Million-38.53%
1999 -NZ$8.56 Million-18.43%
1998 -NZ$10.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.68 B-222,070.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$18.21 B-90,591.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$13.17 B-65,535.84%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-NZ$31.23 Million 55.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-NZ$71.83 Million 256.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.90 B-19,503.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-NZ$4.74 Million-76.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.10 B-604.96%๐Ÿ‡บ๐Ÿ‡ธ USA